Clinical Trials Logo

Gastrointestinal Tolerance clinical trials

View clinical trials related to Gastrointestinal Tolerance.

Filter by:

NCT ID: NCT05827198 Not yet recruiting - Clinical trials for Gastrointestinal Tolerance

Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Candies

Start date: September 12, 2023
Phase: N/A
Study type: Interventional

This study is a randomized, single-blind, crossover trial aiming at evaluating the gastrointestinal tolerance of a sugar replacer blend (inulin + soluble corn fiber + erythritol) at 3 different doses

NCT ID: NCT05369494 Completed - Clinical trials for Gastrointestinal Tolerance

Infants Fed a Hydrolyzed Infant Formula

Start date: May 7, 2022
Phase: N/A
Study type: Interventional

The purpose of this non-randomized, multi-center study is to evaluate the growth, tolerance and compliance of an extensively hydrolyzed infant formula in an intended use population of infants.

NCT ID: NCT05213494 Completed - Clinical trials for Gastrointestinal Tolerance

The Effects of Soluble Corn Fiber on Gastrointestinal Tolerance and Fecal Microbiome in Healthy Children

Start date: May 20, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effects of PROMITOR® Soluble Corn Fiber versus inulin on GI symptoms (tolerance), stool consistency (laxation) and fecal microbiome at levels that could contribute to closing the fiber gap. The dose response effects of PROMITOR® Soluble Corn Fiber in healthy children will also be compared.

NCT ID: NCT05051202 Completed - Clinical trials for Gastrointestinal Tolerance

A Study Assessing the Tolerable Upper Intake Level and Safety of Sugars From Fiber

Start date: June 21, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the upper tolerable limit of Sugars from Fiber

NCT ID: NCT04966299 Recruiting - Insulin Resistance Clinical Trials

Effect of Daily Erythritol Versus Sucrose Intake Over 5 Weeks on Glucose Tolerance in Adolescents

EryAdo
Start date: August 18, 2021
Phase: N/A
Study type: Interventional

Childhood and adolescence are crucial periods for prevention of obesity, as obese children are five times more likely to be obese at adulthood than lean children. To this purpose, sugar consumption should be reduced. The sugar alcohol erythritol is increasingly popular as sugar substitute in the food industry and is also recommended to diabetic patients. The substance is freely available. Recent acute studies show that erythritol has a positive influence on satiation and gastric emptying without affecting insulin and plasma glucose. In this trial, the investigators aim to assess the effect of a chronic intake of erythritol versus sucrose on insulin resistance in healthy adolescents. EryClot-Pilot: Erythritol is also produced by the human body and possibly elevated erythritol levels in the blood are an indication of an increased risk of cardiovascular disease, obesity or diabetes in the future. In a recently published study, a possible effect of erythritol on blood clotting function was described. In this in vitro experiment, increased blood clotting was observed when erythritol was added to clotting cells (platelets) in the test tube. Studies in humans on blood coagulation after administration of erythritol are missing so far. With a pilot study, the investigators study whether erythritol is detectable in the blood after administration of glucose and fructose. Furthermore, the erythritol level in the blood and a possible effect on the blood coagulation function after administration of erythritol will be investigated. These preliminary tests serve to clarify the data situation so that further studies can be based on them.

NCT ID: NCT04945083 Completed - Clinical trials for Gastrointestinal Tolerance

Evaluation of a High Protein, High Calorie Pudding in Adults With/or at Risk for Malnutrition

Start date: January 13, 2021
Phase: N/A
Study type: Interventional

This is a multi-center, prospective, non-randomized, non-blinded, single-arm, single treatment study to evaluate the tolerance of a nutritional pudding.

NCT ID: NCT04745455 Completed - Clinical trials for Gastrointestinal Tolerance

Gastrointestinal Tolerance and Safety of an Infant Formula Containing Prebiotics, Probiotics and Postbiotics.

TREE
Start date: January 22, 2021
Phase: N/A
Study type: Interventional

A study to investigate the gastrointestinal tolerance and safety of a new formula containing prebiotics, probiotics and postbiotics.

NCT ID: NCT04243187 Not yet recruiting - Clinical trials for Gastrointestinal Disease

Evaluation of Gastrointestinal Symptoms Following Chilean Native Beans Consumption

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

The oligosaccharide content (raffinose, stachyose, and verbascose) in legumes would be responsible for gastrointestinal symptoms (bloating, pain, meteorism), associated with its consumption. We would evaluate consumption of 3 varieties of chilean native beans, and evaluate gastrointestinal symptoms produced along with expired H2 test, to correlate this with the amount of oligosaccharide content.

NCT ID: NCT04100460 Not yet recruiting - Clinical trials for Gastrointestinal Tolerance

A Double Blind Study on the Gastrointestinal Effects of Arabinoxylan (Leaf Fiber Extract).

Start date: September 2019
Phase: N/A
Study type: Interventional

The objective of this study is to investigate the effect on Arabinoxylan on gastrointestinal (GI) tolerance, bowel habits, and microbiota in adults. The study is a randomized, placebo-controlled, crossover, single-center trial with 3 study periods separated by minimum 2-week washout periods. 45 healthy adults will be recruited for the trial. Participants will be required to drink a beverage twice a day for 3 weeks during each study period. The beverage will contain either approximately 7.25 grams of Arabinoxylan leaf fiber extract per day, or approximately 14.5 grams of Arabinoxylan leaf fiber extract per day, or will not contain any Arabinoxylan (control). Subjects will record their bowel movements daily, fill out daily questionnaires about their gastrointestinal systems, and record their food intake at specified times during the study. Stool samples will also be collected prior to and at the end of each study period for analysis of bacteria composition.

NCT ID: NCT03945149 Completed - Clinical trials for Gastrointestinal Tolerance

A Clinical Trial to Evaluate the Chronic Safety and Tolerance of Turmipure Gold™ in Healthy Subjects

TURBIO-GOLD
Start date: May 9, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the safety and tolerance of Turmipure Gold™ product during a chronic consumption of 5 weeks in healthy subjects. The hypothesis of this study is that there are no alterations of the gastrointestinal tolerance, of the haematological and biochemical profiles due to Turmipure Gold™ consumption compared to placebo.